AU2002309856B2 - Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms - Google Patents

Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms Download PDF

Info

Publication number
AU2002309856B2
AU2002309856B2 AU2002309856A AU2002309856A AU2002309856B2 AU 2002309856 B2 AU2002309856 B2 AU 2002309856B2 AU 2002309856 A AU2002309856 A AU 2002309856A AU 2002309856 A AU2002309856 A AU 2002309856A AU 2002309856 B2 AU2002309856 B2 AU 2002309856B2
Authority
AU
Australia
Prior art keywords
dpa
polar
composition
epa
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002309856A
Other languages
English (en)
Other versions
AU2002309856A1 (en
Inventor
Jesus Ruben Abril
Wulf Banzhaf
Gerhard Kohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of AU2002309856A1 publication Critical patent/AU2002309856A1/en
Assigned to MARTEK BIOSCIENCES CORPORATION reassignment MARTEK BIOSCIENCES CORPORATION Amend patent request/document other than specification (104) Assignors: MARTEK BIOSCIENCES BOULDER CORPORATION
Application granted granted Critical
Publication of AU2002309856B2 publication Critical patent/AU2002309856B2/en
Priority to AU2009200194A priority Critical patent/AU2009200194B2/en
Assigned to DSM IP ASSETS B.V. reassignment DSM IP ASSETS B.V. Request for Assignment Assignors: MARTEK BIOSCIENCES CORPORATION
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/10—Production of fats or fatty oils from raw materials by extracting
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/86—Products or compounds obtained by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Wood Science & Technology (AREA)
  • Obesity (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002309856A 2001-05-14 2002-05-14 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms Ceased AU2002309856B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2009200194A AU2009200194B2 (en) 2001-05-14 2009-01-20 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29089901P 2001-05-14 2001-05-14
US60/290,899 2001-05-14
PCT/US2002/015454 WO2002092540A1 (en) 2001-05-14 2002-05-14 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsatruated fatty acids from microbes, genetically modified plant seeds and marine organisms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2009200194A Division AU2009200194B2 (en) 2001-05-14 2009-01-20 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms

Publications (2)

Publication Number Publication Date
AU2002309856A1 AU2002309856A1 (en) 2003-05-01
AU2002309856B2 true AU2002309856B2 (en) 2008-10-23

Family

ID=23117970

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002309856A Ceased AU2002309856B2 (en) 2001-05-14 2002-05-14 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
AU2009200194A Ceased AU2009200194B2 (en) 2001-05-14 2009-01-20 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2009200194A Ceased AU2009200194B2 (en) 2001-05-14 2009-01-20 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms

Country Status (8)

Country Link
US (1) US20050129739A1 (enExample)
EP (2) EP1392623A4 (enExample)
JP (3) JP2004536059A (enExample)
AU (2) AU2002309856B2 (enExample)
CA (1) CA2451116C (enExample)
HK (1) HK1151439A (enExample)
MX (1) MX281182B (enExample)
WO (1) WO2002092540A1 (enExample)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566583B1 (en) * 1997-06-04 2003-05-20 Daniel Facciotti Schizochytrium PKS genes
EP1392278A4 (en) * 2001-05-14 2005-05-04 Martek Biosciences Corp PREPARATION AND USE OF A POLAR LIPIDREICH FRACTION WITH STEARIDONIC ACID AND GAMMA LINOLIC ACID FROM PLANT SEEDS AND MICROBES
EP1392623A4 (en) * 2001-05-14 2005-05-04 Martek Biosciences Corp PREPARATION AND USE OF A POLAR LIPID RICH FRACTION CONTAINING HIGHLY UNSATURATED OMEGA-3 AND / OR OMEGA-6 FATTY ACIDS FROM MICROBES, SEEDS OF GENETICALLY MODIFIED PLANTS AND MARINE ORGANISMS
DK1417211T3 (da) 2001-07-27 2007-10-08 Neptune Technologies & Bioress Naturlige phospholipider af marin oprindelse, der indeholder flavonoider og polyumættede phospholipider, og deres anvendelse
US20060165735A1 (en) * 2002-06-18 2006-07-27 Abril Jesus R Stable emulsions of oils in aqueous solutions and methods for producing same
US20060128665A1 (en) * 2002-11-26 2006-06-15 Phares Pharmaceutical Research N.V. Marine lipid compositions
US20070082008A1 (en) * 2003-03-07 2007-04-12 Advanced Bionutrition Corporation Feed formulation for terrestrial and aquatic animals
EP1622467A1 (en) * 2003-05-05 2006-02-08 Denofa AS Fish oils with an altered fatty acid profile, method of producing same and their use
NO347177B1 (no) 2003-08-01 2023-06-19 Basf Plant Science Gmbh Fremgangsmåte for fremstilling av flerumettede fettsyrer i transgene organismer
US8921422B2 (en) 2003-10-01 2014-12-30 The Iams Company Methods and kits for enhancing ability to learn in a puppy or kitten
CA2554932A1 (en) 2004-01-30 2005-08-11 Bionovate Limited Solvent extraction of lipids such as essential fatty acids
CA2558726C (en) 2004-02-27 2017-11-07 Basf Plant Science Gmbh Method for producing unsaturated .omega.-3-fatty acids in transgenic organisms
JP4567047B2 (ja) 2004-02-27 2010-10-20 ビーエーエスエフ プラント サイエンス ゲーエムベーハー トランスジェニック植物における多価不飽和脂肪酸の製造方法
ES2529572T3 (es) 2004-04-22 2015-02-23 Commonwealth Scientific And Industrial Research Organisation Síntesis de ácidos grasos poliinsaturados de cadena larga por células recombinantes
CA3056110C (en) 2004-04-22 2020-07-14 Surinder Pal Singh Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
EP1656839A1 (en) * 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
AU2005305610A1 (en) * 2004-11-17 2006-05-26 Natural Asa Enzymatically synthesized marine phospholipids
CA2588166A1 (en) * 2004-11-19 2006-05-26 Martek Biosciences Corporation Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
DE102005003624A1 (de) * 2005-01-26 2006-07-27 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Herstellung und Anwendung eines antioxidativ wirksamen Extraktes aus Crypthecodinium sp.
GB0506788D0 (en) * 2005-04-04 2005-05-11 Biosea Man As Process
ES2909600T3 (es) 2005-06-07 2022-05-09 Dsm Nutritional Products Ag Microorganismos eucarióticos para producir lípidos y antioxidantes
FR2889957B1 (fr) * 2005-09-01 2008-06-27 Gerard Pieroni Utilisation du dha sous forme de phospholipides pour la preparation d'une composition destinee au traitement de l'insuffisance respiratoire.
DK1965658T3 (en) 2005-11-18 2019-01-21 Commw Scient Ind Res Org FEATURES FOR AQUACULTURE INCLUDING STEARIDONIC ACID
JP4344827B2 (ja) * 2005-11-28 2009-10-14 国立大学法人九州大学 スキゾキトリウム属の微生物を用いた長鎖高度不飽和脂肪酸含有リン脂質の製造方法
AU2007213506A1 (en) * 2006-02-07 2007-08-16 Universitetet I Oslo Omega 3
AR059376A1 (es) 2006-02-21 2008-03-26 Basf Plant Science Gmbh Procedimiento para la produccion de acidos grasos poliinsaturados
NZ547429A (en) 2006-05-24 2009-09-25 Ind Res Ltd Extraction of highly unsaturated lipids with liquid dimethyl ether
JP5658876B2 (ja) * 2006-07-05 2015-01-28 フォトンズ コーポレーション リミテッド 大規模従属栄養培養領域にて産生される超高純度ｅｐａと極性脂質
US9023616B2 (en) 2006-08-01 2015-05-05 Dsm Nutritional Products Ag Oil producing microbes and method of modification thereof
EP2415360A3 (en) * 2006-08-29 2012-02-29 Martek Biosciences Corporation Use of DPA(n-6) oils in infant formula
RU2009111266A (ru) 2006-08-29 2010-10-10 Коммонвелт Сайентифик энд Индастриал Рисерч Организейшн (AU) Синтез жирных кислот
EP2120920A4 (en) * 2007-02-20 2011-06-15 Martek Biosciences Corp OXYLIPINES OF LONG-CHAIN MULTIPLE-UNSATURATED FATTY ACIDS AND METHOD FOR THEIR PREPARATION AND USE
PL2144618T5 (pl) 2007-03-28 2025-07-21 Aker Biomarine Human Ingredients As Bio-skuteczne kompozycje oleju z kryla
US8697138B2 (en) 2007-03-28 2014-04-15 Aker Biomarine As Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
US20110065673A1 (en) * 2007-05-11 2011-03-17 Bizen Chemical Co., Ltd. Novel leukotriene receptor agonist
AU2008288677A1 (en) * 2007-08-17 2009-02-26 Murray Goulburn Co-Operative Co. Limited Compositions comprising phospholipids
EA019387B1 (ru) 2007-09-12 2014-03-31 Мартек Биосайнсиз Корпорейшн Способ получения биологического масла и его использование в способе получения биодизеля
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
US8975299B2 (en) 2007-11-01 2015-03-10 Enzymotec Ltd. Lipid mixture for infant nutrition
US20090202672A1 (en) * 2008-02-11 2009-08-13 Monsanto Company Aquaculture feed, products, and methods comprising beneficial fatty acids
JP2010079993A (ja) * 2008-09-26 2010-04-08 Toshiba Storage Device Corp 記憶装置および記憶装置の調整方法
JP2010090065A (ja) * 2008-10-08 2010-04-22 Nihon Kolmar Co Ltd 化粧料
DK2358882T3 (da) 2008-11-18 2017-11-06 Commw Scient Ind Res Org Enzymer og fremgangsmåder til fremstilling af omega-3 fedtsyrer
CN104042600A (zh) 2009-02-02 2014-09-17 帝斯曼知识产权资产有限公司 改善认知功能和降低心率的方法
US8372812B2 (en) 2009-02-26 2013-02-12 Aker Biomarine Asa Phospholipid and protein tablets
US8207363B2 (en) 2009-03-19 2012-06-26 Martek Biosciences Corporation Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
CN101812484B (zh) * 2009-03-20 2012-04-25 厦门汇盛生物有限公司 高密度培养裂殖壶菌发酵生产dha的方法
EP2272383A1 (en) * 2009-06-22 2011-01-12 SBAE Industries NV Composition Comprising Omega-7 and/or Omega-4 Fatty Acids
US20110177061A1 (en) 2009-07-10 2011-07-21 Martek Biosciences Corporation Methods of treating and preventing neurological disorders using docosahexaenoic acid
US20110082205A1 (en) 2009-10-01 2011-04-07 Panker Cynthia A Docosahexaenoic Acid Gel Caps
EP3335713B1 (en) 2009-10-29 2022-08-31 Acasti Pharma, Inc. Concentrated therapeutic phospholipid compositions
CA2993690C (en) 2010-01-19 2022-03-22 Dsm Ip Assets B.V. Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
FR2955461B1 (fr) * 2010-01-27 2012-04-13 Polaris Ingredient nutritionnel riche en dha et epa
JP5576699B2 (ja) * 2010-04-15 2014-08-20 花王株式会社 Ｇｉｐ上昇抑制剤
SG185578A1 (en) 2010-06-14 2013-01-30 Io Mega Holding Corp Methods for the production of algae derived oils
ITMI20101666A1 (it) * 2010-09-13 2012-03-14 Dmf Dietetic Metabolic Food S R L Composizione a base di acido docosaesaenoico (dha), nel trattamento della fibrosi cistica e della steatosi epatica non alcolica
SI2697345T1 (sl) 2011-04-14 2016-08-31 Polar Omega A/S Proces za izolacijo fosfolipida
MX342216B (es) 2011-07-21 2016-09-20 Dsm Ip Assets Bv Composiciones de acidos grasos.
WO2013024174A1 (en) 2011-08-18 2013-02-21 Dsm Ip Assets B.V. Dha triglyceride, dha free fatty acid, and dha ethyl ester emulsions, and methods of treating spinal cord injury
DE102011113283A1 (de) 2011-09-06 2013-03-07 Johann Wolfgang Goethe-Universität Erhöhung des Lipidgehaltes in Mikroalgen durch genetische Manipulation einer Triacylglycerin (TAG)-Lipase
PL3100717T3 (pl) 2012-01-23 2022-04-19 Restorsea, Llc Kosmetyk zawierający izolat białka z ikry ryb
US8946460B2 (en) 2012-06-15 2015-02-03 Commonwealth Scientific And Industrial Research Organisation Process for producing polyunsaturated fatty acids in an esterified form
US10123986B2 (en) 2012-12-24 2018-11-13 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
US9629820B2 (en) 2012-12-24 2017-04-25 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
CA2894709C (en) * 2012-12-24 2022-08-09 Qualitas Health, Ltd. Eicosapentaenoic acid (epa) formulations
AU2014229307B2 (en) 2013-03-13 2017-08-31 Dsm Nutritional Products Ag Engineering microorganisms
AU2014203179C1 (en) 2013-06-14 2017-05-04 Aker Biomarine Antarctic As Lipid extraction processes
EP2826384A1 (de) 2013-07-16 2015-01-21 Evonik Industries AG Verfahren zur Trocknung von Biomasse
EP3091961A4 (en) 2013-12-13 2017-11-15 Restorsea, LLC Exfoliative hair retention-promoting formulation
WO2015196250A1 (en) 2014-06-27 2015-12-30 Commonwealth Scientific And Industrial Research Organisation Lipid comprising docosapentaenoic acid
US11718577B2 (en) 2013-12-18 2023-08-08 Commonwealth Scientific And Industrial Research Organisation Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids
KR102386838B1 (ko) 2013-12-18 2022-04-15 커먼웰쓰 사이언티픽 앤 인더스트리알 리서치 오거니제이션 장쇄 다중불포화 지방산을 포함하는 지질
GB201400431D0 (en) 2014-01-10 2014-02-26 Aker Biomarine As Phospholipid compositions and their preparation
WO2015175333A1 (en) 2014-05-16 2015-11-19 Restorsea, Llc Biphasic cosmetic
EA037184B1 (ru) * 2014-06-27 2021-02-16 Коммонвелт Сайнтифик Энд Индастриэл Рисерч Организэйшн Липид, содержащий докозапентаеновую кислоту
CA2958439C (en) 2014-10-02 2022-09-20 Evonik Industries Ag Feedstuff of high abrasion resistance and good stability in water, containing pufas
CN106793803B (zh) 2014-10-02 2021-03-09 赢创运营有限公司 通过挤压含pufa的生物质来制备含pufa的饲料的方法
CN107075540A (zh) 2014-10-02 2017-08-18 赢创德固赛有限公司 用于制备具有高细胞稳定性的含pufa生物质的方法
BR112017005388B1 (pt) 2014-10-02 2022-09-13 Evonik Operations Gmbh Alimento para animais contendo biomassa de aurantiochytrium
KR20170091633A (ko) * 2014-12-12 2017-08-09 디에스엠 아이피 어셋츠 비.브이. 수산양식 사료에 사용하기 위한 사료 보충 물질
EP3256553A2 (en) 2015-02-11 2017-12-20 Aker Biomarine Antarctic AS Lipid compositions
WO2016128830A1 (en) 2015-02-11 2016-08-18 Aker Biomarine Antarctic As Lipid extraction processes
AR104042A1 (es) 2015-03-26 2017-06-21 Mara Renewables Corp Producción de alta densidad de biomasa y aceite utilizando glicerol en bruto
CN104914207B (zh) * 2015-06-29 2017-03-15 通威股份有限公司 一种裂殖壶菌藻粉中dha含量的测定方法
CN122256151A (zh) 2015-07-13 2026-06-23 玛拉可再生能源公司 增强木糖的微藻代谢
EP3462902A4 (en) * 2016-06-01 2020-03-04 Cargill, Incorporated FISH FOOD PREPARED FROM OLEAGINOUS PLANTS PRODUCING OMEGA-3 FATTY ACIDS
US10851395B2 (en) 2016-06-10 2020-12-01 MARA Renewables Corporation Method of making lipids with improved cold flow properties
CH713170B1 (de) * 2017-05-22 2018-05-31 La Prairie Group Ag Kosmetische oder dermatologische Zubereitung, enthaltend einen wässrigen und einen lipophilen Fischeiextrakt.
CH713169B1 (de) * 2017-05-22 2018-05-31 La Prairie Group Ag Kosmetische oder dermatologische Zubereitung enthaltend einen Fischeiextrakt.
CN108813634A (zh) * 2018-06-01 2018-11-16 中国科学院青岛生物能源与过程研究所 一种速食型蛋黄寡肽-磷脂型dha双效膳食补充剂及其制备方法
JP2024528332A (ja) * 2021-08-04 2024-07-26 レイウティス ファーマシューティカルズ エルエルピー 肺の炎症を治療するための、吸入薬物送達のための新規オメガ３担体製剤
CN117229848A (zh) * 2023-07-20 2023-12-15 青岛和合汇途工程技术有限公司 一种制取2位dha藻油的湿法分提方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6256497A (ja) * 1985-09-05 1987-03-12 Nisshin Oil Mills Ltd:The エイコサペンタエン酸を含むリン脂質組成物の製造法
WO1992021335A1 (en) * 1991-05-30 1992-12-10 Kabi Pharmacia Ab Phospholipids
US5539133A (en) * 1992-06-12 1996-07-23 Milupa Aktiengesellschaft Process for extracting lipids with a high production of long-chain highly unsaturated fatty acids

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490631A1 (fr) * 1980-09-24 1982-03-26 Roussel Uclaf Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
SU1175486A1 (ru) * 1983-08-31 1985-08-30 Ордена Трудового Красного Знамени Институт Биохимии Им.А.В.Палладина Способ получени комплекса фосфолипидов
CH663951A5 (fr) * 1984-10-10 1988-01-29 Nestle Sa Procede d'enrichissement selectif en acides gras polyinsatures d'un melange contenant des acides gras fractions enrichies obtenues et compositions les contenant.
US4870011A (en) * 1985-01-22 1989-09-26 Director General Of Agency Of Industrial Science And Technology Method for obtaining lipids from fungus bodies
GB8507058D0 (en) * 1985-03-19 1985-04-24 Efamol Ltd Pharmaceutical & dietary compositions
US4816271A (en) * 1987-01-16 1989-03-28 Adelia Scaffidi Skin lotions and creams
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
JP2909508B2 (ja) * 1989-02-14 1999-06-23 マルハ株式会社 オキアミリン脂質の分取方法
WO1992012711A1 (en) * 1991-01-24 1992-08-06 Martek Corporation Microbial oil mixtures and uses thereof
PH31293A (en) * 1991-10-10 1998-07-06 Rhone Poulenc Agrochimie Production of y-linolenic acid by a delta6-desaturage.
JPH0765066B2 (ja) * 1992-05-28 1995-07-12 工業技術院長 紅藻フダラクを原料としたエイコサペンタエン酸含有物質の製造方法
US5583019A (en) * 1995-01-24 1996-12-10 Omegatech Inc. Method for production of arachidonic acid
WO1996033263A1 (en) * 1995-04-17 1996-10-24 JAPAN, represented by DIRECTOR-GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY Novel microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fatty acids by using the microorganisms
JP3985035B2 (ja) * 1995-09-14 2007-10-03 独立行政法人産業技術総合研究所 （ｎ−６）系ドコサペンタエン酸含有油脂ならびに該油脂の製造方法および用途
JPH09194362A (ja) * 1996-01-19 1997-07-29 Bizen Kasei Kk ドコサヘキサエン酸及びエイコサペンタエン酸含有リン脂質を含む組成物
US5883273A (en) * 1996-01-26 1999-03-16 Abbott Laboratories Polyunsaturated fatty acids and fatty acid esters free of sterols and phosphorus compounds
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
US5968809A (en) * 1997-04-11 1999-10-19 Abbot Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
US5993221A (en) * 1997-05-01 1999-11-30 Beth Israel Deaconess Medical Center, Inc. Dietary formulation comprising arachidonic acid and methods of use
GB9715203D0 (en) * 1997-07-19 1997-09-24 Piper Edwina M Composition
AU748220C (en) * 1997-08-01 2003-02-27 Martek Biosciences Corporation DHA-containing nutritional compositions and methods for their production
ES2320851T3 (es) * 2000-01-14 2009-05-29 Epax As Composicion lipidica marina para alimentar organismos acuaticos.
ATE395835T1 (de) * 2000-04-12 2008-06-15 Westfalia Separator Gmbh Verfahren zur fraktionierung von öl- und polar lipid-enthaltenden rohstoffen
EP1392623A4 (en) * 2001-05-14 2005-05-04 Martek Biosciences Corp PREPARATION AND USE OF A POLAR LIPID RICH FRACTION CONTAINING HIGHLY UNSATURATED OMEGA-3 AND / OR OMEGA-6 FATTY ACIDS FROM MICROBES, SEEDS OF GENETICALLY MODIFIED PLANTS AND MARINE ORGANISMS
EP1392278A4 (en) * 2001-05-14 2005-05-04 Martek Biosciences Corp PREPARATION AND USE OF A POLAR LIPIDREICH FRACTION WITH STEARIDONIC ACID AND GAMMA LINOLIC ACID FROM PLANT SEEDS AND MICROBES

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6256497A (ja) * 1985-09-05 1987-03-12 Nisshin Oil Mills Ltd:The エイコサペンタエン酸を含むリン脂質組成物の製造法
WO1992021335A1 (en) * 1991-05-30 1992-12-10 Kabi Pharmacia Ab Phospholipids
US5539133A (en) * 1992-06-12 1996-07-23 Milupa Aktiengesellschaft Process for extracting lipids with a high production of long-chain highly unsaturated fatty acids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Thompson L et al GUT, vol. 35 no. 11, November 1994, pages 1557-1561 *

Also Published As

Publication number Publication date
WO2002092540A1 (en) 2002-11-21
JP2004536059A (ja) 2004-12-02
JP2010065048A (ja) 2010-03-25
JP2008088181A (ja) 2008-04-17
EP1392623A1 (en) 2004-03-03
EP2255668A2 (en) 2010-12-01
EP2255668A3 (en) 2012-04-04
EP1392623A4 (en) 2005-05-04
HK1151439A (en) 2012-02-03
US20050129739A1 (en) 2005-06-16
MX281182B (es) 2010-11-22
CA2451116A1 (en) 2002-11-21
AU2009200194A1 (en) 2009-02-12
CA2451116C (en) 2013-04-09
MXPA03010399A (es) 2004-12-06
AU2009200194B2 (en) 2011-05-19

Similar Documents

Publication Publication Date Title
AU2009200194B2 (en) Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
AU2007225606B2 (en) Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
AU2002309856A1 (en) Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
AU2002318135A1 (en) Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
CN103635564B (zh) 一种分离磷脂的方法
US8609875B2 (en) Oil containing one or more long-chain polyunsaturated fatty acids phospholipids derived from biomass
JP2004536059A5 (enExample)
WO2005083101A1 (ja) 長鎖高度不飽和脂肪酸を構成要素として含むリン脂質の製造方法、およびその利用
KR102639143B1 (ko) 초장쇄 지방산 조성물
JP2006507846A (ja) 海洋ホスホリピド組成物
WO2010010364A2 (en) Process for the purification of oils
Parmentier et al. Polar lipids: n-3 PUFA carriers for membranes and brain: nutritional interest and emerging processes
JP6824506B2 (ja) 脂質組成物
HK1152893A (en) Polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes, and its uses
HK1157577A (en) Oil containing one or more long-chain polyunsaturated fatty acids phospholipids derived from biomass

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE APPLICANT/PATENTEE FROM MARTEK BIOSCIENCES BOULDER CORPORATION TO MARTEK BIOSCIENCES CORPORATION.

MK25 Application lapsed reg. 22.2i(2) - failure to pay acceptance fee
NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO PAY THE ACCEPTANCE FEE HAS BEEN EXTENDED TO 23 FEB 2009.

FGA Letters patent sealed or granted (standard patent)
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE INVENTION TITLE TO READ PRODUCTION AND USE OF A POLAR LIPID-RICH FRACTION CONTAINING OMEGA-3 AND/OR OMEGA-6 HIGHLY UNSATURATED FATTY ACIDS FROM MICROBES, GENETICALLY MODIFIED PLANT SEEDS AND MARINE ORGANISMS

PC Assignment registered

Owner name: DSM IP ASSETS B.V.

Free format text: FORMER OWNER WAS: MARTEK BIOSCIENCES CORPORATION

MK14 Patent ceased section 143(a) (annual fees not paid) or expired